Amphastar Pharmaceuticals (AMPH) Capital Expenditures (2013 - 2026)
Amphastar Pharmaceuticals (AMPH) posted quarterly Capital Expenditures of $4.2 million for Q1 2026, down 42.17% year-over-year from $7.2 million in Q1 2025, and down 49.54% quarter-over-quarter from $8.3 million in Q4 2025.
Amphastar Pharmaceuticals (AMPH) Capital Expenditures (2013 - 2026) Analysis & Trends
Amphastar Pharmaceuticals' Capital Expenditures history runs 14 years deep, the most recent figure standing at $4.2 million for Q1 2026.
- In Q1 2026, Capital Expenditures fell 42.17% year-over-year to $4.2 million; the TTM figure through Mar 2026 stood at $31.8 million (down 19.33% YoY), while the FY2025 annual figure was $34.9 million, down 15.01% from the prior year.
- Capital Expenditures for Q1 2026 stood at $4.2 million, down from $8.3 million in the prior quarter.
- The five-year high for Capital Expenditures was $35.9 million in Q4 2024, with the low at -$24.3 million in Q4 2023.
- The 5-year median for Capital Expenditures is $6.7 million (2022), against an average of $5.3 million.
- The sharpest annual moves came in 2023 and 2025: Capital Expenditures tumbled 1429.86% in 2023, then surged 1376.77% in 2025.
- Amphastar Pharmaceuticals' Capital Expenditures stood at $1.8 million in 2022, then sank by 1429.86% to -$24.3 million in 2023, then soared by 248.01% to $35.9 million in 2024, then sank by 76.97% to $8.3 million in 2025, then plunged by 49.54% to $4.2 million in 2026.
- Business Quant data shows AMPH's Capital Expenditures at $4.2 million in Q1 2026, $8.3 million in Q4 2025, and $20.6 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | 104.00 Mn |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | 117.00 Mn |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | -337.60 Mn |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | 108.00 Mn |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | 52.80 Mn |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | 7.80 Mn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | 33.00 Mn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | - |
| 10 | Amphastar Pharmaceuticals | 943.15 Mn | 653.02 Mn | 93.47 Mn | 8.59 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 8.59 Mn |
| Jun 30, 2026 | 8.59 Mn |
| Mar 31, 2026 | 4.17 Mn |
| Mar 31, 2026 | 4.17 Mn |
| Dec 31, 2025 | 8.27 Mn |
| Dec 31, 2025 | 8.27 Mn |
| Sep 30, 2025 | 20.56 Mn |
| Sep 30, 2025 | 20.56 Mn |
| Jun 30, 2025 | -1.16 Mn |
| Jun 30, 2025 | -1.16 Mn |
| Mar 31, 2025 | 7.22 Mn |
| Mar 31, 2025 | 7.22 Mn |
| Dec 31, 2024 | 35.92 Mn |
| Dec 31, 2024 | 35.92 Mn |
| Sep 30, 2024 | -1.61 Mn |
| Sep 30, 2024 | -1.61 Mn |
| Jun 30, 2024 | -2.06 Mn |
| Jun 30, 2024 | -2.06 Mn |
| Mar 31, 2024 | 8.79 Mn |
| Mar 31, 2024 | 8.79 Mn |